New pill orforglipron was associated with a significant reduction in body weight and better cholesterol, triglycerides and blood pressure.

The ketamine product KETARx made by PharmaTher has been approved by the FDA for use in surgical pain management.

Patients with psoriasis without musculoskeletal involvement are 2.5 times more likely to have synovitis on imaging than control patients.

The management of infantile hemangioma has changed in recent years, shifting from an observation-based approach to active treatment in most patients.

ESK-001, a novel therapy for moderate to severe plaque psoriasis, had acceptable safety and efficacy outcomes at 12 weeks of treatment.

Clinician documentation concerning patient credibility disproportionately undermined Black individuals vs patients of other races.

Topline results were announced from a phase 3 trial evaluating Cylembio (imsapepimut and etimupepimut, adjuvanted) in combination with pembrolizumab as a first-line treatment for advanced melanoma.

Wait times for a bed exceeding 4 hours occurred in 25% of admissions from the emergency room in nonpeak months.

Patients with dermally-based leiomyosarcoma generally have a better prognosis than patients with subcutis-based leiomyosarcoma.

The use of products contaminated with B. cepecia may result in local infections and possibly more serious infections in immunocompromised individuals.

The Gates Foundation will fund $2.5 billion in research on gynecological and obstetric care, contraceptives, STIs, and maternal health.

Researchers have identified an association between varicose veins and central serous chorioretinopathy and serous pigment ...